HeartSciences (HSCS) Net Cash Flow (QoQ) (2021 - 2025)
HeartSciences (HSCS) Net Cash Flow (QoQ) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | HeartSciences | 2.29 Mn | -1.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2025 | -149.65% |
| Jul 31, 2025 | 213.06% |
| Apr 30, 2025 | -2.94% |
| Jan 31, 2025 | -406.02% |
| Oct 31, 2024 | 80.40% |
| Jul 31, 2024 | -15.69% |
| Apr 30, 2024 | -118.19% |
| Jan 31, 2024 | 1,567.13% |
| Oct 31, 2023 | 56.17% |
| Jul 31, 2023 | -301.06% |
| Apr 30, 2023 | 76.38% |
| Jan 31, 2023 | 4.31% |
| Oct 31, 2022 | -135.67% |
| Jul 31, 2022 | 918.21% |
| Apr 30, 2022 | -142.80% |
| Jan 31, 2022 | 224.71% |
| Oct 31, 2021 | -7.05% |